Skip to content

Clinical research based on artificial intelligence to assist in the diagnosis, treatment and prognosis of prostate cancer

Clinical research based on artificial intelligence to assist in the diagnosis, treatment and prognosis of prostate cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119851
Enrollment
Unknown
Registered
2026-03-04
Start date
2026-03-17
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Retrospective patient analysis and training set:None
Retrospective patient validation set:None
Prospective patient validation set:None

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 40 years and 4 ng/ml; 3. Abnormal signal lesions are indicated by multi-parameter MRI of the prostate; 4. Signed informed consent form; 5. Previously, no any prostate-related treatment has been undergone.

Exclusion criteria

Exclusion criteria: 1.Contraindications to MRI examinations, such as metal implants, claustrophobia, etc. 2.Patients with any missing baseline clinical and pathological information; 3.Previous prostate biopsy, surgery, or treatment; 4.Patients with a history of other malignancies; 5.Serious comorbidities or other health problems; 6.Unable to provide informed consent

Design outcomes

Primary

MeasureTime frame
Preoperative accurate prediction results of benign and malignant prostate cancer, grading and subtype of prostate cancer;Results of detailed pathological information after radical prostatectomy;The accuracy of the treatment plan recommended by the artificial intelligence model and the treatment plan actually implemented;

Secondary

MeasureTime frame
Progression-free survival;Overall survival ;Rate of disease recurrence;The PSA index was rechecked after operation;Imaging examination;

Countries

China

Contacts

Public ContactTai Sheng

The First Affiliated Hospital of Anhui Medical University

taishengwk@163.com+86 551 6292 2234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026